TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
ANNX

Annexon Inc

Healthcare · Biotechnology

4.00$ -4.0% vs. previous close Closing price · As of: Oct 6, 2026

Statements

Balance Sheet

Annexon Inc (ANNX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 246 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ANNX
Line item Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
– – – 48 – 36 59 50 40 131 376 356 333 332 310 287 251 221 313 285 269 233 204 298 304 406 379 350 303 265 229 278 263 246
3.0 – – 46 44 33 55 45 35 126 374 354 331 304 275 248 211 181 275 248 233 198 169 264 271 374 344 316 268 231 193 242 228 213
-3.0 – – 44 -44 31 54 44 33 125 371 269 207 100 69 75 113 105 211 140 144 114 133 225 152 157 80 49 97 132 139 162 175 199
3.0 – – 44 44 31 54 44 33 125 371 351 327 302 271 243 207 178 270 243 228 193 165 260 265 369 340 312 264 227 189 238 225 209
– – – 0.2 – 0.2 0.2 0.1 0.0 – 0.0 0.0 0.0 – 0.2 – – – – – – – – – – – – – – – – – – –
– – – – – – – – – – – 0.0 – – – – – – – – – – – – – – – – – – – – – –
– – – – – – 2.2 2.1 2.0 2.0 2.0 1.9 1.4 26 12 38 18 37 17 17 16 16 – – – – – – – – – – – –
– – – 10 – 15 5.1 6.4 7.7 14 10 12 12 36 46 55 50 53 52 54 54 48 47 47 42 45 47 57 59 66 68 66 58 60
– – – 3.3 – 3.9 5.1 4.9 6.3 13 9.0 11 11 10 12 22 17 20 20 22 23 18 17 18 13 17 20 31 34 41 44 43 36 38
– – – – – – – – – – – – – 0.3 0.1 1.2 1.3 1.7 1.8 1.3 1.5 1.6 1.7 2.2 2.3 2.3 2.4 2.5 2.6 2.7 2.8 2.9 3.0 3.1
– – – 1.3 – 2.2 2.6 2.4 3.3 3.1 4.0 3.7 4.5 4.2 4.8 11 9.4 10 6.9 7.4 10 7.2 4.8 5.5 4.0 4.1 6.7 10 10 12 18 15 18 16
2.8 – – 38 38 21 52 44 32 117 365 344 321 295 264 232 201 168 261 231 215 185 157 251 262 361 332 293 244 199 161 212 205 186
– – – -65 – -83 -94 -103 -115 -127 -143 -166 -192 -223 -259 -296 -332 -369 -404 -438 -477 -512 -545 -572 -598 -627 -662 -711 -765 -814 -869 -917 -962 -1,017
0.4 0.4 0.4 0.4 13 13 13 13 13 31 28 38 38 38 38 38 39 39 69 72 74 75 75 78 123 130 140 148 148 148 149 155 194 201

Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?